✦ LIBER ✦

Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol

✍ Scribed by Iván Alvarez; Anna Sureda; Maria D. Caballero; Alvaro Urbano-Ispizua; Josep M. Ribera; Miguel Canales; Javier García-Conde; Guillermo Sanz; Reyes Arranz; Maria T. Bernal; Javier de la Serna; José L. Díez; José M. Moraleda; Daniel Rubió-Félix; Blanca Xicoy; Carmen Martínez; Marivi V. Mateos; Jorge Sierra

Book ID: 116278415
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 325 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

149: Nonmyeloablative stem cell transpla

149: Nonmyeloablative stem cell transplantation in patients with relapsed or refractory Hodgkin lymphoma: Poor evidence of an efficacious graft-versus-Hodgkin’s lymphoma effect

✍ D. Lerner; A.M. Azevedo; R.d.C.B. Tavares; M.C. Nogueira; A. Maiolino; L.F. Bouz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Cost analysis and quality of life assess

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial

✍ M van Agthoven; E Vellenga; W.E Fibbe; T Kingma; C.A Uyl-de Groot 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB

5.3 R-DHAP Immuno-Chemotherapy is an Eff

5.3 R-DHAP Immuno-Chemotherapy is an Effective Remission-Induction Treatment for Fludarabine-Refractory Patients or Those with del17p Before Allogeneic Stem Cell Transplantation; Results of the Planned Interim Analysis of the Dutch-Belgian Prospective Multicenter HOVON88 Trial

✍ M. van Gelder; W. Ghidey; M. Chamuleau; J. Cornelissen; K. Wu; M. Hoogendoorn; S 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 82 KB